As Vyvanse generics bite, Takeda sets out on $900M restructuring plan 0 09.05.2024 18:28 Fiercepharma.com As Vyvanse generics bite, Takeda sets out on $900M restructuring plan zbecker Thu, 05/09/2024 - 11:28
